# RAPIVAB
> **NDA206426** · New Drug Application · Sponsor: BIOCRYST · Approved 2014-12-19
## Drug
- **FDA Application Number:** NDA206426
- **Application type:** New Drug Application
- **Brand name:** RAPIVAB
- **Generic name:** PERAMIVIR
- **Active ingredients:** PERAMIVIR
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BIOCRYST
- **Manufacturer:** BioCryst Pharmaceuticals, Inc.
- **First approval:** 2014-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206426)
---
*AI Analytics · CC0 1.0*